A Review of Infectious Diseases Guidelines’ Incorporation of Economic Evidence is a research paper published in Clinical Infectious Diseases (2022). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: K01 DA048172
NIDA NIH HHS
Grant: L30 DA049289
National Institutes of Health
Grant: 5K01DA048172-04
Integrated Care for Hepatitis C: Current Uptake & Impact on Future Treatment
National Institute on Drug Abuse
FWCI
0.00
Citation Percentile
0.1%
Citation Trend
Fields of Study
MeSH Terms
Keywords